Chemokine Receptor Profiles of T Cells in Patients with Age-Related Macular Degeneration

Purpose To evaluate the expression of multiple chemokine receptors in peripheral blood T cells from patients with age-related macular degeneration (AMD). Materials and Methods Peripheral blood mononuclear cells and/or aqueous humor were obtained from 24 AMD patients and 24 age- and sex-matched healthy controls. Chemokine receptor expression on T cells from peripheral blood was determined by multicolor flow cytometry. The levels of chemokines and cytokines in the aqueous humor from 12 AMD patients and six healthy controls were assessed. Results AMD patients had increased expressions of CCR4 in CD4+ T cells (p=0.007) and CRTh2 in CD8+ T cells (p=0.002), and decreased expressions of CXCR3 in CD4+ T cells (p=0.029) and CXCR3, CCR5, and CX3CR1 in CD8+ T cells (p=0.005, 0.019, and 0.007, respectively). Monocyte chemoattractant protein-1 levels were increased in the aqueous humor from AMD patients (p=0.018), while the levels of interleukin (IL)-4 and IL-22 were significantly decreased compared to controls (p=0.018 and 0.041, respectively). Conclusion The chemokine receptor profiles of T cells are altered in AMD patients compared to healthy controls without noticeable associations with chemokine levels in the aqueous humor. Further evaluation is needed to clarify the role of these alterations in AMD pathogenesis.

[1]  J. Connolly,et al.  Cytokine Profiling in Patients With Exudative Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. , 2019, Investigative ophthalmology & visual science.

[2]  A. D. den Hollander,et al.  Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration. , 2018, Ophthalmology.

[3]  Qiuming Li,et al.  Increased Th1/Th17 Responses Contribute to Low-Grade Inflammation in Age-Related Macular Degeneration , 2017, Cellular Physiology and Biochemistry.

[4]  H. Kawashima,et al.  Changes in multiple cytokine concentrations in the aqueous humour of neovascular age-related macular degeneration after 2 months of ranibizumab therapy , 2017, British Journal of Ophthalmology.

[5]  Richard F Spaide,et al.  IMPROVING THE AGE-RELATED MACULAR DEGENERATION CONSTRUCT: A New Classification System. , 2017, Retina.

[6]  F. Sellebjerg,et al.  Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study , 2017, Scientific Reports.

[7]  U. V. von Andrian,et al.  The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. , 2016, Immunity.

[8]  Zongyi Zhan,et al.  Aqueous humor cytokine profiling in patients with wet AMD , 2016, Molecular vision.

[9]  Yara T. E. Lechanteur,et al.  Nature Genetics Advance Online Publication , 2022 .

[10]  M. Morrison,et al.  Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration , 2015, PloS one.

[11]  M. Nissen,et al.  CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD , 2014, PloS one.

[12]  H. Iijima,et al.  Aqueous Humor Cytokine Levels in Patients with Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration , 2014, Ophthalmic Research.

[13]  H. Goto,et al.  PROFILE OF INTRAOCULAR IMMUNE MEDIATORS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION AND THE EFFECT OF INTRAVITREAL BEVACIZUMAB INJECTION , 2014, Retina.

[14]  M. Nissen,et al.  Dysregulation of CXCR3 expression on peripheral blood leukocytes in patients with neovascular age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.

[15]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[16]  M. Nissen,et al.  Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case–control study , 2014, BMC Ophthalmology.

[17]  S. McColl,et al.  Tailored Immune Responses: Novel Effector Helper T Cell Subsets in Protective Immunity , 2014, PLoS pathogens.

[18]  B. Gelfand,et al.  Immunology of age-related macular degeneration , 2013, Nature Reviews Immunology.

[19]  I. Chowers,et al.  Chemokine receptor expression in peripheral blood monocytes from patients with neovascular age-related macular degeneration. , 2012, Investigative ophthalmology & visual science.

[20]  D. Weinberger,et al.  Monocyte chemoattractant protein‐1 in the aqueous humour of patients with age‐related macular degeneration , 2012, Clinical & experimental ophthalmology.

[21]  K. Matsushima,et al.  Angiostatic effect of CXCR3 expressed on choroidal neovascularization. , 2012, Investigative ophthalmology & visual science.

[22]  J. Hollyfield,et al.  NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components , 2012, Nature Medicine.

[23]  S. Gómez-Martínez,et al.  Chronic and degenerative diseases Obesity, inflammation and the immune system , 2012 .

[24]  Kang Zhang,et al.  Genetics of Immunological and Inflammatory Components in Age-related Macular Degeneration , 2012, Ocular immunology and inflammation.

[25]  S. Sell,et al.  Inflammatory chemokine receptors regulate CD8+ T cell contraction and memory generation following infection , 2011, The Journal of experimental medicine.

[26]  J. Jonas,et al.  Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. , 2010, Archives of ophthalmology.

[27]  F. Tacke,et al.  Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults , 2010, BMC Immunology.

[28]  U. Schmidt-Erfurth,et al.  Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. , 2009, Ophthalmology.

[29]  Justine R. Smith,et al.  CCR3 is a therapeutic and diagnostic target for neovascular age-related macular degeneration , 2009, Nature.

[30]  Thomas J. Lukas,et al.  The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration , 2008, PloS one.

[31]  Joe G Hollyfield,et al.  Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.

[32]  P. Debré,et al.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.

[33]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[34]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[35]  Sergio Romagnani,et al.  CXC chemokines: the regulatory link between inflammation and angiogenesis. , 2004, Trends in immunology.

[36]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[37]  Eiji Sakurai,et al.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.

[38]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[39]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[40]  A. Ramé [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.